Thrivent Financial for Lutherans’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.11M | Buy |
|
|||||
|
2025
Q2 | $3.98M | Buy |
|
|||||
|
2025
Q1 | $2.96M | Sell |
|
|||||
|
2024
Q4 | $85.7M | Sell |
|
|||||
|
2024
Q3 | $83M | Sell |
|
|||||
|
2024
Q2 | $124M | Sell |
|
|||||
|
2024
Q1 | $130M | Sell |
|
|||||
|
2023
Q4 | $127M | Sell |
|
|||||
|
2023
Q3 | $116M | Sell |
|
|||||
|
2023
Q2 | $158M | Buy |
|
|||||
|
2023
Q1 | $136M | Buy |
|
|||||
|
2022
Q4 | $91.6M | Sell |
|
|||||
|
2022
Q3 | $104M | Sell |
|
|||||
|
2022
Q2 | $192M | Buy |
|
|||||
|
2022
Q1 | $222M | Buy |
|
|||||
|
2021
Q4 | $224M | Sell |
|
|||||
|
2021
Q3 | $203M | Sell |
|
|||||
|
2021
Q2 | $188M | Sell |
|
|||||
|
2021
Q1 | $161M | Buy |
|
|||||
|
2020
Q4 | $175M | Sell |
|
|||||
|
2020
Q3 | $165M | Sell |
|
|||||
|
2020
Q2 | $143M | Buy |
|
|||||
|
2020
Q1 | $130M | Buy |
|
|||||
|
2019
Q4 | $158M | Sell |
|
|||||
|
2019
Q3 | $224M | Sell |
|
|||||
|
2019
Q2 | $195M | Buy |
|
|||||
|
2019
Q1 | $200M | Sell |
|
|||||
|
2018
Q4 | $161M | Buy |
|
|||||
|
2018
Q3 | $150M | Sell |
|
|||||
|
2018
Q2 | $128M | Buy |
|
|||||
|
2018
Q1 | $85.5M | Buy |
|
|||||
|
2017
Q4 | $63.1M | Buy |
|
|||||
|
2017
Q3 | $61.2M | Buy |
|
|||||
|
2017
Q2 | $64.2M | Sell |
|
|||||
|
2017
Q1 | $66.2M | Sell |
|
|||||
|
2016
Q4 | $71.1M | Buy |
|
|||||
|
2016
Q3 | $75.7M | Sell |
|
|||||
|
2016
Q2 | $63.6M | Sell |
|
|||||
|
2016
Q1 | $69M | Buy |
|
|||||
|
2015
Q4 | $57M | Buy |
|
|||||
|
2015
Q3 | $50.3M | Buy |
|
|||||
|
2015
Q2 | $24M | Buy |
|
|||||
|
2015
Q1 | $22.8M | Buy |
|
|||||
|
2014
Q4 | $20.4M | Buy |
|
|||||
|
2014
Q3 | $255K | Hold |
|
|||||
|
2014
Q2 | $215K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $269 | Buy |
|